| Anticancer Fund

Approval of pancreatic cancer trial with perioperative use of β-blocker and anti-inflammatory drug

Fri, 09/07/2018 - 12:00

Anonymous donor funds almost € 400.000 for pancreatic cancer trial

Fri, 09/07/2018 - 12:00

Almost 1000 hours of cancer questions: PIT facts & figures

Fri, 08/24/2018 - 12:00

Omics-driven drug repurposing in rare cancers

Pantziarka, P. & Meheus, L. (2018). Omics-driven drug repurposing as a source of innovative therapies in rare cancers. Expert Opinion on Orphan Drugs, 6(9), 513-517. doi:10.1080/21678707.2018.1500690

Tue, 07/24/2018 - 12:00

Zoom in: ACF for patients

Fri, 07/20/2018 - 12:00

Zoom in: ACF for patients

Mon, 07/16/2018 - 12:00

Guy Buyens becomes new medical director of the Anticancer Fund

Wed, 07/04/2018 - 12:00

New uses for old drugs

Pantziarka, P., Pirmohamed, M., & Mirza, N. (2018). New uses for old drugs: Low cost generics are an untapped source of therapeutic innovation. BMJ, 361, k2701. doi:10.1136/bmj.k2701

Tue, 06/26/2018 - 12:00